A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)
Clinical trial NCT01014065 · COMPLETED
Trial details
- NCT number
- NCT01014065
- Sponsor
- AHS Cancer Control Alberta
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2011-07-01
- Primary completion
- 2012-11-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.